NCT01038726 Effects of Exercise and Cognitive Training on Cognitive Function in Older Adults Status COMPLETED Phase NA
NCT01035164 Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01028911 A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease Status TERMINATED Phase PHASE1
NCT01028053 Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT01025466 Exelon Patch and Combination With Memantine Comparative Trial Status COMPLETED Phase PHASE4
NCT01024660 The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil Status COMPLETED Phase EARLY_PHASE1
NCT01023867 Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia Status COMPLETED Phase NA
NCT01023425 Clinical Trial of Donepezil Between the Naive Group and the Switching Group Status COMPLETED Phase NA
NCT01019421 Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01018875 Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01009255 Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01005862 Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00991419 To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden Status COMPLETED Phase PHASE2
NCT00990613 A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin Status COMPLETED Phase PHASE1
NCT00988624 A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine) Status COMPLETED Phase PHASE1
NCT00988598 A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00987220 Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid Status COMPLETED Phase N/A